Development of intelligence in early treated phenylketonuria

Area of Science:

• Neuroscience
• Genetics
• Developmental Psychology

Background:

• Phenylketonuria (PKU) is a genetic disorder requiring early dietary intervention.
• Longitudinal studies are crucial for understanding the long-term effects of PKU treatment on cognitive development.

Purpose of the Study:

• To review existing longitudinal studies on intelligence in early-treated PKU patients.
• To assess the impact of phenylalanine (Phe) levels on IQ development and identify optimal management thresholds.

Main Methods:

• Review of longitudinal studies analyzing intelligence in PKU patients.
• Correlation analysis between blood Phe levels during early childhood and later IQ scores.

Main Results:

• IQ development stabilizes after age 10, irrespective of dietary relaxation.
• Each 300 mumol/l increase in preschool Phe levels corresponds to a half standard deviation decrease in IQ.
• Children with Phe levels <400 mumol/l in early/middle childhood exhibit near-normal cognitive outcomes.
• PKU appears to affect global IQ rather than domain-specific skills.

Conclusions:

• Early and consistent management of Phe levels below 400 mumol/l is critical for optimal cognitive outcomes in PKU.
• Further research, including control groups and interdisciplinary approaches, is needed to fully understand PKU's long-term neurological impact and refine treatment strategies.
• The cognitive development and potential risks in older adult PKU patients remain an underexplored area.